{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:09:32Z","timestamp":1760645372025,"version":"3.44.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.humpath.2006.10.021","type":"journal-article","created":{"date-parts":[[2007,4,19]],"date-time":"2007-04-19T07:28:22Z","timestamp":1176967702000},"page":"995-1002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Consequences of p16 tumor suppressor gene inactivation in mycosis fungoides and S\u00e9zary syndrome and role of the bmi-1 and ras oncogenes in disease progression"],"prefix":"10.1016","volume":"38","author":[{"given":"Chunlei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albena","family":"Toulev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jivko","family":"Kamarashev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Zhong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Dummer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udo","family":"D\u00f6bbeling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2006.10.021_bib1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1040-0486(97)80009-9","article-title":"Cutaneous lymphomas","volume":"9","author":"Burg","year":"1997","journal-title":"Curr Probl Dermatol"},{"key":"10.1016\/j.humpath.2006.10.021_bib2","first-page":"1061","article-title":"Cutaneous T-cell lymphoma: pathogenesis and treatment","volume":"14","author":"Girardi","year":"2000","journal-title":"Oncology"},{"key":"10.1016\/j.humpath.2006.10.021_bib3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/path.1341","article-title":"Expression of apoptosis regulators in cutaneous T cell lymphoma","volume":"200","author":"Zhang","year":"2003","journal-title":"J Path"},{"key":"10.1016\/j.humpath.2006.10.021_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2133.1995.tb02488.x","article-title":"p53 protein expression in cutaneous T-cell lymphoma","volume":"133","author":"Lauritzen","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.humpath.2006.10.021_bib5","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1346-8138.1995.tb03438.x","article-title":"Infrequent expression of protein p53 in epidermotropic variants of cutaneous T-cell lymphoma","volume":"22","author":"de Misa","year":"1995","journal-title":"J Dermatol"},{"key":"10.1016\/j.humpath.2006.10.021_bib6","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1046\/j.1523-1747.1998.00167.x","article-title":"Overexpression of p53 in cutaneous T cell lymphoma: relationship to large cell transformation and disease progression","volume":"110","author":"Li","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.humpath.2006.10.021_bib7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1600-0560.1999.tb01860.x","article-title":"p53 tumor suppressor gene mutations in transformed cutaneous T-cell lymphoma: a study of 12 cases","volume":"26","author":"Marrogi","year":"1999","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2006.10.021_bib8","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1600-0560.1997.tb01319.x","article-title":"p53 and bcl-2 expression do not correlate with prognosis in primary cutaneous large T-cell lymphomas","volume":"24","author":"van Haselen","year":"1997","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2006.10.021_bib9","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/366704a0","article-title":"A new regulatory motif in cell-cycle control causing specific inhibition of cyclinD\/CDK4","volume":"366","author":"Serrano","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2006.10.021_bib10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/371257a0","article-title":"p15INK4B is a potential effector of TGF-beta\u2013induced cell cycle arrest","volume":"371","author":"Hannon","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2006.10.021_bib11","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1101\/gad.8.24.2939","article-title":"Growth suppression by p18, a p16INK4\/MTS1- and p14INK4B\/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function","volume":"8","author":"Guan","year":"1994","journal-title":"Genes & Dev"},{"key":"10.1016\/j.humpath.2006.10.021_bib12","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1128\/MCB.15.5.2682","article-title":"Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16 INK","volume":"15","author":"Chan","year":"1995","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.humpath.2006.10.021_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0092-8674(00)80714-X","article-title":"Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16INK4A, TGF-beta and contact inhibition","volume":"97","author":"Zhang","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2006.10.021_bib14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.8153634","article-title":"A cell cycle regulator potentially involved in genesis of many tumor types","volume":"264","author":"Kamb","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.humpath.2006.10.021_bib15","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/368753a0","article-title":"Deletions of the cyclin-dependent kinase\u20134 inhibitor gene in multiple human cancers","volume":"368","author":"Nobori","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2006.10.021_bib16","doi-asserted-by":"crossref","first-page":"11045","DOI":"10.1073\/pnas.91.23.11045","article-title":"Mutations and altered expression of p16INK in human cancer","volume":"91","author":"Okamoto","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2006.10.021_bib17","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0002-9440(10)65028-6","article-title":"p16(INK4a) gene alterations are frequent in lesions of mycosis fungoides","volume":"156","author":"Navas","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2006.10.021_bib18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.0022-202x.2001.01682.x","article-title":"Frequent abnormalities of the p15 and p16 genes in mycosis fungoides and S\u00e9zary syndrome","volume":"118","author":"Scarisbrick","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.humpath.2006.10.021_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.leukres.2005.08.012","article-title":"Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencing","volume":"30","author":"Nagasawa","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.humpath.2006.10.021_bib20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/16476","article-title":"The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus","volume":"397","author":"Jacobs","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2006.10.021_bib21","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1182\/blood.V97.12.3896","article-title":"Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma","volume":"97","author":"van Kemenade","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2006.10.021_bib22","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0002-9440(10)64583-X","article-title":"Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease","volume":"15","author":"Raaphorst","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2006.10.021_bib23","first-page":"2409","article-title":"BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas","volume":"61","author":"Bea","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2006.10.021_bib24","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1054\/bjoc.2001.1791","article-title":"The bmi-1 oncoprotein is differently expressed in non\u2013small cell lung cancer and correlates with INK4A-ARF locus expression","volume":"84","author":"Vonlanthen","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2006.10.021_bib25","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1101\/gad.13.20.2678","article-title":"Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc\u2013induced apoptosis via INK4a\/ARF","volume":"13","author":"Jacobs","year":"1999","journal-title":"Genes & Dev"},{"key":"10.1016\/j.humpath.2006.10.021_bib26","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0344-0338(11)80423-1","article-title":"Mycosis fungoides: expression of c-myc p62 p53, bcl-2 and PCNA proteins and absence of association with Epstein-Barr virus","volume":"190","author":"Kanavaros","year":"1994","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.humpath.2006.10.021_bib27","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood.V93.1.260","article-title":"Constitutive and IL-7\/ IL-15 stimulated DNA-binding of Myc, Jun, and novel Myc-like proteins in cutaneous T cell lymphoma (CTCL) cells","volume":"93","author":"Qin","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2006.10.021_bib28","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.4049\/jimmunol.166.10.5925","article-title":"Distinct BMI-1 and EZH2 expression patterns in thymocytes and mature T cells suggest a role for Polycomb genes in human T cell differentiation","volume":"166","author":"Raaphorst","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.humpath.2006.10.021_bib29","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/nm779","article-title":"CDK4 coexpression with Ras generates malignant human epidermal tumorigenesis","volume":"8","author":"Lazarov","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.humpath.2006.10.021_bib30","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/22788","article-title":"Essential role for oncogenic ras in tumour maintenance","volume":"400","author":"Chin","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2006.10.021_bib31","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2144\/97221bm19","article-title":"Method for simultaneous RNA and DNA isolation from biopsy material, culture cells, plants and bacteria","volume":"22","author":"D\u00f6bbeling","year":"1997","journal-title":"BioTechniques"},{"key":"10.1016\/j.humpath.2006.10.021_bib32","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1046\/j.1365-2230.1997.2610674.x","article-title":"Lack of expression of the recombination activating genes RAG-1 and RAG-2 in cutaneous T cell lymphoma (CTCL): pathogenetic implications","volume":"22","author":"D\u00f6bbeling","year":"1997","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.humpath.2006.10.021_bib33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s004030050395","article-title":"Reduced expression of CDKN2a\/P16INK4a in mycosis fungoides","volume":"291","author":"Peris","year":"1999","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.humpath.2006.10.021_bib34","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1182\/blood.V57.3.452.452","article-title":"Patterns of cell proliferation and cell migration in the S\u00e9zary syndrome","volume":"57","author":"Bunn","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2006.10.021_bib35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/path.1394","article-title":"Evidence for at least three alternative mechanisms targeting the p16 INK4A\/cyclin D\/Rb pathway in penile carcinoma, one of which is mediated by high-risk human papillomavirus","volume":"201","author":"Ferreux","year":"2003","journal-title":"J Path"},{"key":"10.1016\/j.humpath.2006.10.021_bib36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0960-9822(02)00410-4","article-title":"Signalling pathways: jack of all cascades","volume":"6","author":"Cahill","year":"1996","journal-title":"Curr Biol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817707000068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817707000068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:32:54Z","timestamp":1758645174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817707000068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0046817707000068"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2006.10.021","relation":{},"ISSN":["0046-8177"],"issn-type":[{"type":"print","value":"0046-8177"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consequences of p16 tumor suppressor gene inactivation in mycosis fungoides and S\u00e9zary syndrome and role of the bmi-1 and ras oncogenes in disease progression","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2006.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}